Geode Capital Management
VVOS icon

Geode Capital Management’s Vivos Therapeutics VVOS Stock Holding History

Geode Capital Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113K Buy
95,543
+39,256
+70% +$62.9K ﹤0.01% 4104
2025
Q4 		$114K Buy
56,287
+2,998
+6% +$7.42K ﹤0.01% 4063
2025
Q3 		$165K Sell
53,289
-4,613
-8% -$20.9K ﹤0.01% 3988
2025
Q2 		$183K Buy
57,902
+553
+1% +$1.4K ﹤0.01% 3902
2025
Q1 		$163K Buy
57,349
+12,522
+28% +$49.2K ﹤0.01% 3903
2024
Q4 		$192K Buy
44,827
+16,025
+56% +$53.5K ﹤0.01% 3920
2024
Q3 		$75.2K Buy
28,802
+8,111
+39% +$21.2K ﹤0.01% 4171
2024
Q2 		$45.9K Buy
+20,691
New +$50.5K ﹤0.01% 4298
2023
Q4 		– Sell
-8,078
Closed -$38.8K – 4684
2023
Q3 		$38.8K Hold
8,078
– – ﹤0.01% 4480
2023
Q2 		$103K Hold
8,078
– – ﹤0.01% 4322
2023
Q1 		$68.9K Hold
8,078
– – ﹤0.01% 4446
2022
Q4 		$81K Sell
8,078
-18
-0.2% -$263 ﹤0.01% 4466
2022
Q3 		$131K Hold
8,096
– – ﹤0.01% 4433
2022
Q2 		$261K Buy
8,096
+26
+0.3% +$1.08K ﹤0.01% 4111
2022
Q1 		$540K Buy
8,070
+3,611
+81% +$236K ﹤0.01% 3896
2021
Q4 		$250K Buy
4,459
+1,505
+51% +$121K ﹤0.01% 4385
2021
Q3 		$298K Buy
2,954
+1,048
+55% +$110K ﹤0.01% 4273
2021
Q2 		$235K Buy
1,906
+1,411
+285% +$230K ﹤0.01% 4276
2021
Q1 		$82K Buy
+495
New +$88.4K ﹤0.01% 4335

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management's VVOS Position: Q1 2026 in Review

Geode Capital Management increased its Vivos Therapeutics (VVOS) stake by 70% in Q1 2026, buying an estimated $62.9K and bringing the position to 95,543 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #4104.

Geode Capital Management first reported a position in VVOS in Q1 2021 and has held it in 19 quarters since. The position peaked at $540K in Q1 2022. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • Geode Capital Management held 95,543 shares of Vivos Therapeutics worth $113K as of Q1 2026.
  • Geode Capital Management bought 39,256 Vivos Therapeutics shares in Q1 2026, an estimated $62.9K.
  • Vivos Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4104 holding.
  • Geode Capital Management first reported a position in Vivos Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Geode Capital Management's Vivos Therapeutics position peaked at $540K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.